Skip to main content
. 2020 Nov 11;7:384. doi: 10.1038/s41597-020-00727-4

Fig. 3.

Fig. 3

Distributions of drug-design relevant properties calculated for the Plus subset of SAVI (a) Molecular weight. (b) XlogP294. (c) Total Polar Surface Area (Å2). (d) Fraction of sp3 hybridized carbons. (e) Number of rotatable bonds. (f) QED (Quantitative Estimate of Druglikeness) score71. (g) PAINS (Pan Assay Interference Compounds) counts. (h) Bruns & Watson demerits for Identifying Potentially Reactive or Promiscuous Compounds66.